AZD-4205
AZD-4205 Basic information
- Product Name:
- AZD-4205
- Synonyms:
-
- AZD-4205
- JAK1 inhibitor 3
- AZD 4205 (AZD4205)
- JAK1-IN-3
- 1-Piperazineacetamide, N-[3-[2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-α,4-dimethyl-, (αR)-
- Golidocitinib
- AZD 4205,Janus kinase,Golidocitinib,AZD-4205,JAK,Inhibitor,inhibit
- (2R)-N-(3-{2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide
- CAS:
- 2091134-68-6
- MF:
- C25H31N9O2
- MW:
- 489.58
- Mol File:
- 2091134-68-6.mol
More
Less
AZD-4205 Chemical Properties
- Density
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: soluble
- form
- A solid
- pka
- 14.63±0.30(Predicted)
- color
- Light yellow to yellow
- InChIKey
- CVCVOSPZEVINRM-QEIABERDNA-N
- SMILES
- N(C1C=CC=C2C(C3C=CN=C(NC4=CN(C)N=C4OC)N=3)=CNC=12)C(=O)[C@H](N1CCN(C)CC1)C |&1:27,r|
More
Less
AZD-4205 Usage And Synthesis
Uses
Golidocitinib (AZD4205) is a selective JAK1 inhibitor, with an IC50 of 73 nM, weakly inhibits JAK2 (IC50>14.7 μM), and shows little inhibition on JAK3 (IC50>30 μM)[1].
in vivo
Golidocitinib (12.5 mg/kg BID (twice daily), 25 m/kg BID or 50 mg/kg BID, p.o.) alone has increasing antitumor effects, and ehances the antitumor activity of osimertinib, compared to treatment with osimertinib alone in mice bearing NCI-H1975 cells[1].
IC 50
JAK1: 73 nM (IC50)
References
[1] Annika Birgitta Margareta ?STRAND, et al. Compounds and methods for inhibiting jak. WO2017050938A1.
AZD-4205Supplier
Changzhou Borl Biotechnology Co.,LTD Gold
- Tel
- 13606124132;13656121842
- luyan0021@163.com
CAREBIO PHARMA Gold
- Tel
- 18501057619 18501057619;
- jackyfan@rebornpharma.com
Zhengzhou Haode Pharmaceutical Technology Co.,Ltd Gold
- Tel
- 18037386321
- 3330511471@qq.com
Shanghai Lollane Biological Technology Co.,Ltd.
- Tel
- 021-52996696，15000506266 15000506266
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com